Paper Details

  1. Home
  2. Paper Details

Fate and function of hepatitis-C-virus-specific T-cells during peginterferon-alpha2b therapy for acute hepatitis C.

Author: AslanNuray, BuggischPeter, CinerAyse, CornbergMarkus, JaeckelElmar, KubitschkeAnne, MannsMichael P, SarrazinChristoph, SchlaphoffVerena, WedemeyerHeiner, WiegandJohannes

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Clinical Trial, Phase IIA Phase II trial is a trial that further evaluates the efficacy and safety of a new drug or treatment, whose safety has been confirmed to some extent in a Phase I trial, in a small number of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Strong immune responses to hepatitis C virus (HCV) are associated with the body naturally clearing the virus. However, recent studies have found that the number of a type of immune cell (CD8+ T-cells) decreases during interferon treatment. This suggests that successful treatment for acute HCV may not depend on the body's immune system.
Paper Details　
Original Abstract of the Article :
Strong hepatitis C virus (HCV)-specific T-cell responses are associated with spontaneous clearance of acute hepatitis C. However, recent studies described a decline in HCV-specific CD8+ T-cells during interferon treatment, suggesting that the success of acute HCV therapy might be independent of adap...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/17591020

データ提供：米国国立医学図書館（NLM）

The Intricate Dance of T-Cells in Hepatitis C Treatment

Hepatitis C, like a relentless desert wind, can wreak havoc on the liver. This research delves into the intricate interplay of [T-cells] in the body's response to [peginterferon-alpha2b therapy] for [acute hepatitis C] . It's like unraveling the secrets of a hidden oasis within the vast and complex desert of the immune system.

The Dynamic Role of T-Cells in Hepatitis C Treatment

The study explores the dynamic role of [HCV-specific T-cells] in [acute hepatitis C] and their response to [peginterferon-alpha2b therapy] . It highlights the complex interplay between the immune system and antiviral treatment, like a delicate dance between different forces in the desert. While [T-cells] are crucial in fighting [HCV], their behavior during [peginterferon therapy] is not always straightforward.

A Deeper Understanding of Hepatitis C Treatment

This study provides valuable insights into the complex mechanisms of [HCV] treatment and the role of [T-cells] in the process. It underscores the importance of continued research to understand the intricacies of the immune response to antiviral therapy, like exploring the hidden depths of the desert landscape.

Dr.Camel's Conclusion

This research provides a fascinating glimpse into the complex interplay of [T-cells] in the fight against [hepatitis C]. It's a reminder that the body's immune response to treatment is a delicate dance, like navigating the shifting sands of a desert landscape. This study emphasizes the need for further research to optimize treatment strategies for [hepatitis C] and understand the full potential of the immune system in combating this challenging disease.

Date :
  1. Date Completed 2007-08-06
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

17591020

DOI: Digital Object Identifier

17591020

Related Literature

Article Analysis
・Effective treatment of hepatitis c
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.